The role of the urologist in smoking cessation: Why is it important?

Sosnowski, Roman; Przewoźniak, Krzysztof

doi:10.1016/j.urolonc.2014.07.011

Cited by 30 publications

(20 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Estes resultados comprovam o que estudos anteriores concluíram, que a assistência dos urologistas a fumadores em contexto do CB é insuficiente, baseando-se fundamentalmente no aconselhamento. 27,[45][46][47] Os urologistas e os médicos de família, pressionados pelos constrangimentos do tempo de consulta, sentem que a promoção de cessação é pouco eficiente e desapontante, o que pode justificar o pouco investimento na prática clínica diária. [46][47][48][49] Este estudo apresenta algumas limitações, para além das referidas anteriormente, que deverão ser tidas em conta na apreciação das conclusões: 1) o desenho transversal do estudo prejudica a atribuição de causalidade dos dados 2) os doentes não participantes eram mais velhos e do sexo feminino, duas características associadas à ausência de tabagismo -este facto poderá ter condicionado uma sobrevalorização da taxa de fumadores 3) os dados da história tabágica foram baseados nas entrevistas, sem a confirmação bioquímica da abstinência, existindo o risco da subestimação do número de fumadores ativos 50,51 4) o tempo entre o diagnóstico e a entrevista não foi homogéneo, o que acarreta um risco inerente de viés de memória.…”

Section: Discussionunclassified

Smoking Cessation after Bladder Cancer Diagnosis

Mota

Sousa

Botelho³

et al. 2018

Acta Med Port

View full text Add to dashboard Cite

RESUMOIntrodução: O tabagismo é um importante fator de risco para o desenvolvimento, recorrência e progressão do cancro da bexiga. Este estudo pretendia analisar os hábitos tabágicos após o diagnóstico em doentes com cancro da bexiga. Adicionalmente, foi avaliado o reconhecimento do tabagismo como fator de risco e a atuação médica na promoção da cessação tabágica. Smoking was acknowledged as a risk factor by 74.4% of the sample, with only 51.3% of ever smokers and 24.4% of non-smokers recognizing smoking as the leading risk factor (p = 0.008). The presence of other household smokers were significantly higher in patients who continued smoking (40%) than in ex-smokers after diagnosis (4.2%) (p = 0.005). The majority of smokers at diagnosis (83.1%) were advised to quit by their urologist, but only one smoker (1.7%) was offered any specific intervention to aid in cessation. Discussion: Smoking is not recognized as the leading risk factor for bladder cancer. This limited awareness, associated with the known difficulties in quitting smoking and the observed lack of smoking cessation interventions, may account for the high current smoking prevalence, albeit in line with other studies. Conclusion: This study highlights the need for efficient smoking cessation programs directed to bladder cancer patients. Keywords: Smoking; Smoking Cessation; Urinary Bladder Neoplasms INTRODUÇÃOO cancro da bexiga (CB) é uma das neoplasias malignas mais frequente do trato urinário, com uma incidência 3 -4 vezes mais elevada nos homens do que nas mulheres. [1][2][3] É o sétimo cancro mais frequente no mundo, com aproximadamente 336 000 novos casos estimados/ano, em particular nos países desenvolvidos.2,4 Em Portugal, segundo dados do relatório de doenças oncológicas, o CB tem a oitava maior taxa de incidência, tendo sido responsável pela morte de 940 doentes no ano de 2014, valor que manifesta uma tendência de crescimento face aos anos anteriores. 5O CB é um dos principais carcinomas associados ao tabaco; estudos epidemiológicos evidenciam uma relação consistente entre o tabagismo e o risco de CB, responsável por mais de 50% dos casos nos países desenvolvidos. 1,[6][7][8][9] Os ex-fumadores e os fumadores apresentam um risco duas e quatro vezes superior, respetivamente, com maiores incrementos deste consoante a intensidade e a duração do consumo. 7,9 O consumo de tabaco no contexto oncológico não é apenas relevante pelo seu potencial carcinogénico. A evidência científica atual aponta para um pior prognóstico, maior risco de recorrência e de progressão nos doentes

show abstract

Section: Discussionunclassified

Smoking Cessation after Bladder Cancer Diagnosis

Mota

Sousa

Botelho³

et al. 2018

Acta Med Port

View full text Add to dashboard Cite

show abstract

“…Given the wide variety of genitourinary diseases affected by cigarette smoking, along with patients’ varying degrees of tobacco dependence, urologists appear well positioned to influence patient tobacco use (Figure 1) [17]. Studies have shown that patients who receive smoking cessation advice from their urologist are 2.3 times more likely to attempt to quit [8].…”

Section: Role Of Urologists In Smoking Cessationmentioning

confidence: 99%

“…The diagnosis of cancer may represent a window of opportunity during which patients are particularly motivated to quit smoking and are receptive to advice. This teachable moment has been shown to result in successful smoking cessation in 48% of BCa patients and was the most often cited reason for quitting [18]. Smokers with a new diagnosis of BCa are at least five times more likely to quit smoking than those in the general population (48% vs. 10%, respectively; p <0.001).…”

Section: Role Of Urologists In Smoking Cessationmentioning

confidence: 99%

“…Brief interventions along with straightforward smoking cessation advice such as “As your urologist, I must advise you that smoking is risky for your health, and it would be important for you to stop“ has been shown to increase smoking cessation [18]. Indeed, failure to address smoking is interpreted as a sign of acceptance by the patient.…”

Section: Role Of Urologists In Smoking Cessationmentioning

confidence: 99%

“…Indeed, failure to address smoking is interpreted as a sign of acceptance by the patient. Optimal smoking cessation counselling can be further individualized and in some cases rely on the strict collaboration with specialized institutions [18]. Continuing to assist the patient in abstaining from smoking by a referral to a smoking cessation clinic, telephone quite line, psychologist support, and/or a patient support group is often a necessary element in order to achieve permanent smoking cessation.…”

Section: Role Of Urologists In Smoking Cessationmentioning

confidence: 99%

See 2 more Smart Citations

Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation

Sosnowski

Bjurlin

Verze

et al. 2016

CEJU

View full text Add to dashboard Cite

IntroductionCigarette smoking is the single greatest preventable cause of disease and death. Our literature review highlights the increased risk of cigarette smoking and kidney cancer, bladder cancer and prostate cancer.Material and methodsSmoking cessation improves outcomes at all stages of these disease processes, where patients who quit for 10–20 years appear to obtain a similar risk as those who have never smoked, even after diagnosis of disease.ResultsUrologists, however, very seldom provide smoking cessation assistance. By applying brief smoking cessation intervention techniques, physicians’ posses an effective means of providing quitting advice.ConclusionsPatients who receive smoking cessation advice from their urologist are 2.3 times more likely to attempt to quit. Urologists are well-positioned to screen, counsel, and promote cessation at regular intervals, which may improve quit rates, and ultimately improve our patients’ outcomes.

show abstract

Intervention training of urology healthcare staff to counsel acute care inpatients on smoking cessation: An evaluation study

2022

View full text Add to dashboard Cite

Aim To evaluate the differences, following intervention training, in the knowledge, attitudes, role perception, self‐capacity and intention of urology staff to counsel inpatients on smoking cessation. Design A descriptive evaluation study of intervention training in counselling on smoking cessation. The study was designed following guidance by the Medical Research Council. Methods The evaluation was based on a closed‐end questionnaire with four time‐point measurements from May 2018–December 2019 (N = 29 at each time‐point). A repeated measure within‐subjects ANOVA was conducted to explore the variance in participants' attitudes, role perception, self‐capacity and intention to counsel patients regarding smoking cessation. Eta squared and Bonferroni post hoc tests were used to interpret the results. Results No change was observed in the research variables after theoretical science‐based learning of the smoking hazards and the benefits of cessation. A statistically significant difference was found following procedural knowledge based on training, practical experience and skill development.

show abstract

The role of the urologist in smoking cessation: Why is it important?

Cited by 30 publications

References 45 publications

Smoking Cessation after Bladder Cancer Diagnosis

Smoking Cessation after Bladder Cancer Diagnosis

Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation

Intervention training of urology healthcare staff to counsel acute care inpatients on smoking cessation: An evaluation study

Contact Info

Product

Resources

About